Optimi Health Corp OPTH

Morningstar Rating
$3.17 −0.34 (9.57%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

OPTH is trading at a LOCK|L>%mxp premium.
Price
$3.17
Fair Value
LOCK|^$wq^Ts
Uncertainty
LOCK|$Y <%!T$
1-Star Price
LOCK|?%>Y?d
5-Star Price
LOCK|jBywt^G
Economic Moat
LOCK|#dF
Capital Allocation
—

Trading Information

Previous Close Price
$3.50
Day Range
$3.04–3.54
52-Week Range
$0.17–6.40
Bid/Ask
$1.29 / $4.74
Shares Outstanding
5.73M
Market Cap
$18.12M
Volume/Avg
54,635 / 46,326

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
70.40
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
9

Valuation

Metric
OPTH
Price/Earnings (Normalized)
—
Price/Book Value
1.61
Price/Sales
70.40
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
OPTH
Quick Ratio
1.62
Current Ratio
1.73
Interest Coverage
−5.99
Quick Ratio
OPTH

Profitability

Metric
OPTH
Return on Assets (Normalized)
−43.79%
Return on Equity (Normalized)
−89.65%
Return on Invested Capital (Normalized)
−46.14%
Return on Assets
OPTH

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|<mc>#NQLOCK|@RM?$69B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|mr>Ql<&#LOCK|g&tT%$49B
Haleon PLC ADR
HLN
LOCK|xY@s&vLOCK|LL$42B
Zoetis Inc Class A
ZTS
LOCK|Lz<Dj$^LOCK|?!^$31B
Viatris Inc
VTRS
LOCK|!!^vc%LOCK|dK$20B
Elanco Animal Health Inc
ELAN
LOCK|@TGLOCK|Tx!$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|M%%F%qLOCK|Zj^$11B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|>Btw>?TLOCK|%y@$6B
Prestige Consumer Healthcare Inc
PBH
LOCK|@cyBs!LOCK|n!@#$$2B
Perrigo Co PLC
PRGO
LOCK|Xbl?@%QLOCK|m&$2B

Sponsor Center